U.S. FDA classifies Aurobindo arm’s North Carolina plant VAI
With the unit classified as Voluntary Action Indicated (VAI), pending applications for multiple inhalers and other dosage forms filed from this facility can now progress through the U.S.
FDA’s review process, the parent company said
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.thehindu.com — the content belongs to The Hindu - International.
